Turkish Journal of Nephrology
Original Article

Current Status of Renal Replacement Therapy in Turkey: A Summary of Turkish Society of Nephrology 2013 Annual Registry Report

1.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye

2.

Ankara Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Ankara, Türkiye

3.

Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Antalya, Türkiye

Turkish J Nephrol 2015; 24: 10-16
DOI: 10.5262/tndt.2015.1001.02
Read: 3153 Downloads: 958 Published: 04 February 2019

OBJECTIVE: Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis and transplantation on annual basis. Registry reports are printed every year as a booklet and this is the 24th year of registry reports. The registry is in close collaboration with international registries. 

MATERIAL and METHODS: In this paper data from the 2013 registry report are summarized, additionally yearly trends in the management of end stage renal disease are also provided. 

RESULTS: The number of patients on renal replacement therapy is rapidly increasing, at the end of 2013, 66711 patients were on renal replacement therapy. The prevalence and incidence of end stage renal disease was 870 and 138 per million population respectively. Diabetes was the most important cause of end stage renal disease. Hemodialysis (79%) was the most common type of treatment modality, followed by transplantation (14%) and peritoneal dialysis (7%). 

CONCLUSION: End stage renal disease is a very important and growing health problem for our country. Renal registry is a leading tool for providing current and sound data on this public health problem.

Files
EISSN 2667-4440